Show simple item record

dc.contributor.authorKhondee, Supang
dc.contributor.authorBaoum, Abdulgader Ahmed
dc.contributor.authorSiahaan, Teruna J.
dc.contributor.authorBerkland, Cory J.
dc.identifier.citationKhondee, S., Baoum, A., Siahaan, T. J., & Berkland, C. (2011). Calcium-crosslinked LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. Molecular Pharmaceutics, 8(3), 788–798.
dc.description.abstractTargeted gene delivery using non-viral vectors is a highly touted scheme to reduce the potential for toxic or immunological side effects by reducing dose. In previous reports, TAT polyplexes with DNA have shown relatively poor gene delivery. The transfection efficiency has been enhanced by condensing TAT/DNA complexes to a small particle size using calcium. To explore the targetability of these condensed TAT complexes, LABL peptide targeting intercellular cell-adhesion molecule-1 (ICAM-1) was conjugated to TAT peptide using a polyethylene glycol (PEG) spacer. PEGylation reduced the transfection efficiency of TAT, but TAT complexes targeting ICAM-1 expressing cells regained much of the lost transfection efficiency. Targeted block peptides properly formulated with calcium offer promise for gene delivery to ICAM-1 expressing cells at sites of injury or inflammation.en_US
dc.publisherAmerican Chemical Societyen_US
dc.rightsThis document is the Accepted Manuscript version of a Published Work that appeared in final form in Molecular Pharmaceutics, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see
dc.subjectTargeted gene deliveryen_US
dc.subjectCalcium crosslinkingen_US
dc.titleCalcium-crosslinked LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cellsen_US
kusw.kuauthorKhondee, Supang
kusw.kuauthorBaoum, Abdulgader Ahmed
kusw.kuauthorSiahaan, Teruna J.
kusw.kuauthorBerkland, Cory J.
kusw.kudepartmentPharmaceutical Chemistryen_US
kusw.oanotesPer SHERPA/RoMEO 5/8/2017: Author's Pre-print: grey tick subject to Restrictions below, author can archive pre-print (ie pre-refereeing) Restrictions:

Must obtain written permission from Editor Must not violate ACS ethical Guidelines

Author's Post-print: grey tick subject to Restrictions below, author can archive post-print (ie final draft post-refereeing) Restrictions:

If mandated by funding agency or employer/ institution If mandated to deposit before 12 months, must obtain waiver from Institution/Funding agency or use AuthorChoice 12 months embargo

Publisher's Version/PDF: cross author cannot archive publisher's version/PDF General Conditions:

On author's personal website, pre-print servers, institutional website, institutional repositories or subject repositories Non-Commercial Must be accompanied by set statement (see policy) Must link to publisher version Publisher's version/PDF cannot be used
kusw.oaversionScholarly/refereed, author accepted manuscripten_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US

Files in this item


This item appears in the following Collection(s)

Show simple item record